hUMSCs Restore Uterine Function by Inhibiting Endometrial Fibrosis via Regulation of the MMP-9/TIMP-1 Ratio in CDDP-Induced Injury Rats

The fertility of females of childbearing age who are cured of cancer by chemotherapy is gradually declining globally. As a broad-spectrum chemotherapy drug in clinic, the damage of cisplatin (CDDP) to female reproductive function cannot be ignored. At present, the study of CDDP damage to the uterus is not sufficient, and the exact mechanism needs to be further explored. Therefore, we conducted this research to determine whether uterine injury in CDDP-induced injury rats might be improved by human umbilical cord mesenchymal stem cells (hUMSCs) and to further explore the precise mechanism. The rat model of CDDP-induced injury was established by intraperitoneal injection of CDDP, and hUMSCs were injected into the tail vein 7 days later. In vivo, uterine function in CDDP-induced injury rats was affected after hUMSC transplantation. In vitro, the specific mechanism was further explored from the cell and protein levels. Overall, the specific reason of CDDP-induced uterine dysfunction in rats was endometrial fibrosis, which was significantly improved after hUMSC transplantation. Further investigation of the mechanism found that hUMSCs could regulate the ratio of matrix metalloproteinase-9 (MMP-9)/tissue inhibitor of metalloproteinase-1 (TIMP-1) in endometrial stromal cells (EnSCs) after CDDP injury.

[1]  A. Wójtowicz,et al.  Perspective on Stem Cell Therapy in Organ Fibrosis: Animal Models and Human Studies , 2021, Life.

[2]  S. Carson,et al.  Diagnosis and Management of Infertility: A Review. , 2021, JAMA.

[3]  F. Ozatik,et al.  Cisplatin decreases HOXA13 and alphaVBeta3 integrin levels in the uterus. , 2021, Taiwanese journal of obstetrics & gynecology.

[4]  Sheng Wang,et al.  What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment? , 2020, Stem cell research & therapy.

[5]  M. Martinez-Fierro,et al.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases , 2020, International journal of molecular sciences.

[6]  Hongqin Zhang,et al.  hUMSCs regulate the differentiation of ovarian stromal cells via TGF-β1/Smad3 signaling pathway to inhibit ovarian fibrosis to repair ovarian function in POI rats , 2020, Stem Cell Research & Therapy.

[7]  Lianshuang Zhang,et al.  hUMSC transplantation restores ovarian function in POI rats by inhibiting autophagy of theca-interstitial cells via the AMPK/mTOR signaling pathway , 2020, Stem Cell Research & Therapy.

[8]  T. Quirico-Santos,et al.  Liver fibrosis improvement in chronic hepatitis C after direct acting-antivirals is accompanied by reduced profibrogenic biomarkers-a role for MMP-9/TIMP-1. , 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[9]  S. Garzon,et al.  Ion Channels in The Pathogenesis of Endometriosis: A Cutting-Edge Point of View , 2020, International journal of molecular sciences.

[10]  A. Winship,et al.  Do cancer therapies damage the uterus and compromise fertility? , 2019, Human reproduction update.

[11]  S. Garzon,et al.  The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights , 2019, International journal of molecular sciences.

[12]  Yu-Show Fu,et al.  Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly , 2019, Theranostics.

[13]  Hongqin Zhang,et al.  The effects of human umbilical cord-derived mesenchymal stem cell transplantation on endometrial receptivity are associated with Th1/Th2 balance change and uNK cell expression of uterine in autoimmune premature ovarian failure mice , 2019, Stem Cell Research & Therapy.

[14]  Sumit Ghosh.  Cisplatin: The first metal based anticancer drug. , 2019, Bioorganic chemistry.

[15]  Jia Liu,et al.  A mechanisms of endometrial fibrosis and the potential application of stem cell therapy. , 2019, Discovery medicine.

[16]  C. Farquhar,et al.  Female subfertility , 2019, Nature Reviews Disease Primers.

[17]  L. Goldsmith,et al.  The role of mesenchymal–epithelial transition in endometrial function , 2018, Human reproduction update.

[18]  N. Pereza,et al.  Matrix metalloproteinase and tissue inhibitors of metalloproteinases gene polymorphisms in disorders that influence fertility and pregnancy complications: A systematic review and meta-analysis. , 2018, Gene.

[19]  Y. Li,et al.  Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase , 2018, Stem Cell Research & Therapy.

[20]  Yu-Show Fu,et al.  Xenograft of Human Umbilical Mesenchymal Stem Cells from Wharton’s Jelly Differentiating into Osteocytes and Reducing Osteoclast Activity Reverses Osteoporosis in Ovariectomized Rats , 2018, Cell transplantation.

[21]  Michael Raghunath,et al.  Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative Medicine , 2017, Stem cells translational medicine.

[22]  Yang-Hsin Shih,et al.  Xenograft of human umbilical mesenchymal stem cells from Wharton’s jelly as a potential therapy for rat pilocarpine-induced epilepsy , 2016, Brain, Behavior, and Immunity.

[23]  V. Vullo,et al.  Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors , 2016, International journal of molecular sciences.

[24]  Yun Xu,et al.  Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy , 2015, Expert opinion on biological therapy.

[25]  Wei Cao,et al.  Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications , 2014, Nature Immunology.

[26]  P. Tchounwou,et al.  Cisplatin in cancer therapy: molecular mechanisms of action. , 2014, European journal of pharmacology.

[27]  G. Quinn,et al.  Why Healthcare Providers Should Focus on the Fertility of AYA Cancer Survivors: It’s Not Too Late! , 2013, Front. Oncol..

[28]  J. Brosens,et al.  The motile and invasive capacity of human endometrial stromal cells: implications for normal and impaired reproductive function. , 2013, Human reproduction update.

[29]  Zeev Blumenfeld,et al.  Chemotherapy and fertility. , 2012, Best practice & research. Clinical obstetrics & gynaecology.

[30]  R. Barr,et al.  Adolescents, young adults, and cancer—the international challenge , 2011, Cancer.

[31]  K. Wood,et al.  Mesenchymal stromal cells: facilitators of successful transplantation? , 2010, Cell stem cell.

[32]  Shonagh Walker,et al.  The status of platinum anticancer drugs in the clinic and in clinical trials. , 2010, Dalton transactions.

[33]  D. Modi,et al.  HOXA10 signals on the highway through pregnancy. , 2009, Journal of reproductive immunology.

[34]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[35]  T. Strowitzki,et al.  The human endometrium as a fertility-determining factor. , 2006, Human reproduction update.

[36]  Charles J Malemud,et al.  Matrix metalloproteinases (MMPs) in health and disease: an overview. , 2006, Frontiers in bioscience : a journal and virtual library.

[37]  Gillian Murphy,et al.  Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.

[38]  P. Moutsatsou,et al.  Estrogen and Progesterone Receptors in the Endometrium , 1997, Annals of the New York Academy of Sciences.

[39]  J. Pfeilschifter,et al.  Differential modulation of the cytokine-induced MMP-9/TIMP-1 protease-antiprotease system by the mTOR inhibitor rapamycin. , 2011, Biochemical pharmacology.